ELI LILLY AND COMPANY revenue for the last year amounted to 30.09 T CLP, the most of which — 30.09 T CLP — came from its highest performing source at the moment, Human Pharmaceutical Products, the year earlier bringing 24.31 T CLP. The greatest contribution to the revenue figure was made by United States — last year it brought ELI LILLY AND COMPANY 19.22 T CLP, and the year before that — 15.49 T CLP.